01/15/2025
3:14 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
3:27 PM | Dellora Investments LP (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2024
7:02 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:04 PM | Hunter Robyn (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:07 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:09 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:49 PM | Almenoff June Sherie (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:54 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:58 PM | Doogan Declan (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:54 PM | MCGAULEY THOMAS (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/05/2024
12:47 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
|
11/26/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2024
6:14 PM | Lind Global Fund II LP (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
11:39 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:21 AM | CVI Investments, Inc. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:35 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:15 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
7:14 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
09/12/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
09/12/2024
3:15 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
09/10/2024
4:19 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/30/2024
3:19 PM | Tenax Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/30/2024
3:20 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/23/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/19/2024
5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/15/2024
3:19 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/14/2024
5:47 PM | Tenax Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/14/2024
2:19 PM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/13/2024
3:45 PM | Tenax Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:35 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:42 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:43 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:23 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
4:00 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:01 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:01 PM | Tenax Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
8:01 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
7:42 AM | Tenax Therapeutics (Filer)
| Form DEFA14A | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
04/26/2024
7:50 AM | Tenax Therapeutics (Filer)
| Form ARS | |
04/26/2024
7:30 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
7:30 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/14/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/14/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:56 PM | Tenax Therapeutics (Filer)
| Form POS AM | |
04/11/2024
3:59 PM | Tenax Therapeutics (Filer)
| Form POS AM | |
03/28/2024
1:02 PM | Tenax Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:45 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/26/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/23/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/20/2024
7:33 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
10:28 AM | CVI Investments, Inc. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
02/15/2024
6:36 PM | Lind Global Fund II LP (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
02/07/2024
8:01 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
02/06/2024
8:20 AM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/06/2024
7:56 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:24 PM | Tenax Therapeutics (Filer)
| Form S-1/A | |
01/22/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
